The exciting therapeutic developments we're seeing in our life sciences portfolio has led to several investments in specialty facilities and plants. In San Diego California's biotech hub, our state-of-the-art properties house top innovators like biotech company BioAtla.

In Australia, we've invested in drug manufacturing plants, adding leading-edge upgrades to our BioCina cGMP plants in Perth and Adelaide. These state-of the art facilities, boasts advance equipment and technologies that meet the highest global regulatory standards.